Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Carcinoma, Hepatocellular 4Recurrence 3Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Colorectal Neoplasms 3Burkitt Lymphoma 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Prolymphocytic, B-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Leukemia, B-Cell 2Glioma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Simpson-Golabi-Behmel syndrome 1Sarcoma, Synovial 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1

Interventions

Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Simpson-Golabi-Behmel syndrome × Immunotherapy, Adoptive × Clear all
NCT04121273 2021-03-03

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1 Unknown
20 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡